Navigation Links
LegalView Re-Launches its Avandia Information Portal with News of the Type 2 Diabetes Drug's Risks and Dangers

LegalView reintroduced its Avandia practice area to include updated information for victims of the drug's side effects. Avandia has been linked to the development of early on-set osteoporosis and heart failure among patients.

Denver (PRWEB) October 21, 2008 --, the most comprehensive legal resource available on the Web, recently re-launched its Avandia information portal to provide the most up-to-date news on potential Avandia side effects recently associated with patients taking the drug.

Those affected by the drug's side effects are advised to locate a pharmaceutical attorney as it may be necessary to develop an Avandia lawsuit to retrieve monetary compensation for the damages caused by the prescription drug.

Avandia (risiglitazone maleate) is a type 2 diabetes treatment from GlaxoSmithKline and was released in mid-1999. The drug was part of a new group of drugs that work to use the body's natural insulin to regulate blood glucose levels. In May 2007, the U.S. Food and Drug Administration (FDA) issued a health advisory for the drug, notating its potential risks for causing heart attacks and heart-related deaths among Avandia patients.

Additionally, in June 2007 the New England Journal of Medicine reported the severe dangers of heart failure among Avandia patients and found a 43 percent increase of heart attack among drug patients. Another study conducted by a group of Swiss researchers also found that those consuming Avandia were more likely to develop early on-set osteoporosis and bone fractures/bone breaks while taking the drug. Because of the Avandia risks of osteoporosis and heart failure it is important for Avandia patients to consult their physician if they feel that they may be at risk for developing any of the Avandia risks.

Type 2 diabetes is a serious and potentially fatal condition that is difficult to treat. According to the American Diabetes Association (ADA), several million Americans currently suffer from diabetes. Individuals who have the condition are at an increased risk for developing complications such as heart disease, kidney damage, blindness and nerve damage. Because of this potential for complications it becomes increasingly important and dangerous when prescription drugs, such as Avandia, add to the risk of causing diabetes complications. Individuals who have been given a prescription for Avandia should consult a physician immediately if they feel they may develop any of the drug's side effects. Additionally, contacting an Avandia law firm may be important to protect patients. Consulting a knowledgeable Avandia lawyer may provide insight into developing an Avandia class action lawsuit to retrieve monetary compensation for the damages caused by the drug.

About LegalView: is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at


Read the full story at

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin
2. LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients
3. LegalView Brain Injury Site Reports Department of Veteran Affairs Request for Research on TBI and Soldiers
4. LegalView Highlights Top Brain Injury Rehabilitation Hospitals in the United States - 5.3 Million Americans Suffer from TBI
5. LegalView Reports Details of War Veteran Brain Injuries Overlooked By Officials for Years
6. LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug
7. LegalView Re-launching Truck Accident Injury Information Portal with Updated News and Information on the Costly and Dangerous Accidents
8. LegalView Reports Cancer Risk for St. Louis Residents After Unapproved Asbestos Removal During Demolition
9. LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis
10. LegalView Reintroduces its Medical Malpractice Information Portal with Updated Links to Finding Immediate Legal Assistance
11. MedQuist Re-launches New, Improved Web Site
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... Patients at Serenity ... have come together on Thanksgiving Day to share the things that they are ... the Serenity Point YouTube channel, patients displayed what they wrote on index cards, ...
(Date:11/26/2015)... ... November 26, 2015 , ... CognisantMD and ... diagnostic imaging in the Waterloo region. Using the Ocean Platform, family physicians can ... from their electronic medical record (EMR) without the need for redundant patient entry ...
(Date:11/26/2015)... ... 2015 , ... The Catalent Applied Drug Delivery Institute today ... dose form selection in early phase drug development. The first of these is ... together the UK’s emerging life sciences companies, corporate partners, and investors, at Milton ...
(Date:11/26/2015)... , ... November 26, 2015 , ... PRMA Plastic Surgery ... 19, 2015, our surgeons performed their 6,000th free flap breast reconstruction surgery! , “What ... up every day excited to rebuild lives and it’s an honor to have served ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... new set of retro-fused, self-animating trailer titles with ProTrailer: Vintage. This newly styled ... These classically-influenced trailer titles work with any font, giving users limitless opportunities to ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... Ein neuer Kombinationsansatz vereint ... --> Ein neuer Kombinationsansatz vereint Immuntherapie ... --> Ein neuer Kombinationsansatz vereint Immuntherapie ... Clinical Cancer Research vom 6. November ... vom 6. November 2015 berichtet. --> ...
(Date:11/27/2015)... Nov. 26, 2015 ... of the "2016 Global Tumor Marker ... Volume and Sales Segment Forecasts, Innovative Technologies, ... report to their offering. --> ... the "2016 Global Tumor Marker Testing ...
(Date:11/26/2015)... Carolina , 26 november 2015 /PRNewswire/ ... (AAIPharma/CML) kondigt de geplande investering aan van ... van de laboratoria en het mondiale hoofdkantoor ... De uitbreiding zal resulteren in extra kantoorruimte ... voldaan aan de groeiende behoeften van de ...
Breaking Medicine Technology: